The biology and function of fibroblasts in cancer

Among all cells, fibroblasts could be considered the cockroaches of the human body. They survive severe stress that is usually lethal to all other cells, and they are the only normal cell type that can be live-cultured from post-mortem and decaying tissue. Their resilient adaptation may reside in their intrinsic survival programmes and cellular plasticity. Cancer is associated with fibroblasts at all stages of disease progression, including metastasis, and they are a considerable component of the general host response to tissue damage caused by cancer cells. Cancer-associated fibroblasts (CAFs) become synthetic machines that produce many different tumour components. CAFs have a role in creating extracellular matrix (ECM) structure and metabolic and immune reprogramming of the tumour microenvironment with an impact on adaptive resistance to chemotherapy. The pleiotropic actions of CAFs on tumour cells are probably reflective of them being a heterogeneous and plastic population with context-dependent influence on cancer.

[1]  John B. Shoven,et al.  I , Edinburgh Medical and Surgical Journal.

[2]  Mathias Duval.  Atlas d'embryologie / , 1889 .

[3]  D. Tarin,et al.  Ultrastructural features of wound healing in mouse skin. , 1969, Journal of anatomy.

[4]  G. Gabbiani,et al.  Myofibroblasts in an avascular fibrous tissue. , 1973, Laboratory investigation; a journal of technical methods and pathology.

[5]  G. Gabbiani,et al.  Myofibroblasts in human granulation tissue. , 1974, Human pathology.

[6]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[7]  J. Seidman,et al.  Activation of lung connective tissue cells in vitro. , 1979, The American review of respiratory disease.

[8]  Castor Cw,et al.  Activation of lung connective tissue cells in vitro. , 1979 .

[9]  E. Manseau,et al.  Pathogenesis of desmoplasia. I. Immunofluorescence identification and localization of some structural proteins of line 1 and line 10 guinea pig tumors and of healing wounds. , 1984, Journal of the National Cancer Institute.

[10]  P. Durning,et al.  FIBROBLASTS FROM PATIENTS WITH BREAST CANCER SHOW ABNORMAL MIGRATORY BEHAVIOUR IN VITRO , 1984, The Lancet.

[11]  M. Bissell,et al.  Wounding and its role in RSV-mediated tumor formation. , 1985, Science.

[12]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[13]  R. Chiquet‐Ehrismann,et al.  Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis , 1986, Cell.

[14]  A. Paulen.  A time for reassessment. , 1986, Cancer nursing.

[15]  A. Gown,et al.  HHF35, a muscle actin-specific monoclonal antibody. II. Reactivity in normal, reactive, and neoplastic human tissues. , 1987, The American journal of pathology.

[16]  Y. Kawarada,et al.  Tenascin is a stromal marker for epithelial malignancy in the mammary gland. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[17]  N. Davidson,et al.  Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Schor,et al.  Foetal and cancer patient fibroblasts produce an autocrine migration-stimulating factor not made by normal adult cells. , 1988, Journal of cell science.

[19]  W. Schürch,et al.  Smooth‐muscle differentiation in stromal cells of malignant and non‐malignant breast tissues , 1988, International journal of cancer.

[20]  D. Goeddel,et al.  Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.

[21]  Peter K. Vogt,et al.  Obligatory wounding requirement for tumorigenesis in v-jun transgenic mice , 1990, Nature.

[22]  H. Rodemann,et al.  Characterization of human renal fibroblasts in health and disease: I. Immunophenotyping of cultured tubular epithelial cells and fibroblasts derived from kidneys with histologically proven interstitial fibrosis. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  H. Rodemann,et al.  Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  P. Masiello,et al.  Effect of dietary restriction on the age-related changes in hormone-regulated protein breakdown , 1991, Aging.

[25]  L. Liotta,et al.  Tumor cell interactions with the extracellular matrix during invasion and metastasis. , 1993, Annual review of cell biology.

[26]  O. Petersen,et al.  Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[27]  B. Chauffert,et al.  In vivo and in vitro invasiveness of a rat colon‐cancer cell line maintaining E‐cadherin expression: An enhancing role of tumor‐associated myofibroblasts , 1994, International journal of cancer.

[28]  F. Strutz,et al.  Identification and characterization of a fibroblast marker: FSP1 , 1995, The Journal of cell biology.

[29]  J. Tait,et al.  Challenges and opportunities. , 1996, Journal of psychiatric and mental health nursing.

[30]  M J Bissell,et al.  Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. , 1996, Physiological reviews.

[31]  Z. Werb,et al.  Matrix Metalloproteinase Stromelysin-1 Triggers a Cascade of Molecular Alterations That Leads to Stable Epithelial-to-Mesenchymal Conversion and a Premalignant Phenotype in Mammary Epithelial Cells , 1997, The Journal of cell biology.

[32]  A. Gressner,et al.  Tumor‐dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis , 1997, Hepatology.

[33]  R. Xavier,et al.  Tumor Induction of VEGF Promoter Activity in Stromal Cells , 1998, Cell.

[34]  A B West,et al.  Myofibroblasts: paracrine cells important in health and disease. , 2000, Transactions of the American Clinical and Climatological Association.

[35]  D. Powell,et al.  Powell, D. W. et al. Myofibroblasts. I. Paracrine cells important in health and disease. Am. J. Physiol. 277, C1-C9 , 1999 .

[36]  Anthony J. Guidi,et al.  Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  D. Pinkel,et al.  The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis , 1999, Cell.

[38]  J. Samet,et al.  Sleep-disordered Breathing and Hypertension: More Research Is Still Needed , 2000 .

[39]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[40]  F. Strutz,et al.  Role of fibroblast activation in inducing interstitial fibrosis. , 2000, Journal of nephrology.

[41]  J. Banchereau,et al.  IL-6 switches the differentiation of monocytes from dendritic cells to macrophages , 2000, Nature Immunology.

[42]  P E Thorpe,et al.  Ultrastructural Localization of the Vascular Permeability Factor/Vascular Endothelial Growth Factor (VPF/VEGF) Receptor-2 (FLK-1, KDR) in Normal Mouse Kidney and in the Hyperpermeable Vessels Induced by VPF/VEGF-expressing Tumors and Adenoviral Vectors , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[43]  W. Dalton,et al.  Adhesion to fibronectin via β1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR) , 2000, Oncogene.

[44]  J. Samet.  Does idiopathic pulmonary fibrosis increase lung cancer risk? , 2000, American journal of respiratory and critical care medicine.

[45]  J. Ringel,et al.  Transforming Growth Factor-β1 Induces Desmoplasia in an Experimental Model of Human Pancreatic Carcinoma , 2001 .

[46]  R. Weinberg,et al.  Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. , 2001, Experimental cell research.

[47]  K Satyamoorthy,et al.  N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. , 2001, Cancer research.

[48]  M J Bissell,et al.  The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. , 2001, Development.

[49]  B. Hinz,et al.  Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.

[50]  David Botstein,et al.  Diversity, topographic differentiation, and positional memory in human fibroblasts , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Zena Werb,et al.  Stromal Effects on Mammary Gland Development and Breast Cancer , 2002, Science.

[52]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[53]  M. Selman,et al.  Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder , 2001, Respiratory research.

[54]  Rakesh K. Kumar.  Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder , 2002, Respiratory Research.

[55]  A. Desmoulière,et al.  Normal and Pathologic Soft Tissue Remodeling: Role of the Myofibroblast, with Special Emphasis on Liver and Kidney Fibrosis , 2003, Laboratory Investigation.

[56]  R. Kalluri.  Basement membranes: structure, assembly and role in tumour angiogenesis , 2003, Nature reviews. Cancer.

[57]  R. Knuechel,et al.  Tumor‐associated fibroblasts recruit blood monocytes into tumor tissue , 2003, European journal of immunology.

[58]  Joan L. Monaco,et al.  Acute wound healing an overview. , 2003, Clinics in plastic surgery.

[59]  Paul J. Williams,et al.  Anti-alpha4 integrin antibody suppresses the development of multiple myeloma and associated osteoclastic osteolysis. , 2004, Blood.

[60]  T. Oda,et al.  Overexpression of TGF-β by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer , 2004, British Journal of Cancer.

[61]  Kristian Pietras,et al.  High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.

[62]  Raghu Kalluri,et al.  Cancer without disease , 2004, Nature.

[63]  M. Colombo,et al.  Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. , 2004, Gastroenterology.

[64]  T. Hirano,et al.  IL-6 Regulates In Vivo Dendritic Cell Differentiation through STAT3 Activation1 , 2004, The Journal of Immunology.

[65]  R. Weinberg,et al.  Reconstruction of functionally normal and malignant human breast tissues in mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[66]  M. Washington,et al.  TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004, Science.

[67]  Zhongyun Dong,et al.  Modulation of tumor cell response to chemotherapy by the organ environment , 1994, Cancer and Metastasis Reviews.

[68]  G. Gabbiani,et al.  Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction , 1971, Experientia.

[69]  A. Agarwal,et al.  PAR1 Is a Matrix Metalloprotease-1 Receptor that Promotes Invasion and Tumorigenesis of Breast Cancer Cells , 2005, Cell.

[70]  M. Salmon,et al.  A stromal address code defined by fibroblasts. , 2005, Trends in immunology.

[71]  Jun Yao,et al.  Distinct epigenetic changes in the stromal cells of breast cancers , 2005, Nature Genetics.

[72]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[73]  K. Crooks.  More Similarities than Differences , 2005 .

[74]  G. McCaughan,et al.  Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX‐2 human stellate cell line , 2005, Hepatology.

[75]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[76]  M. Grigorian,et al.  Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene. , 2005, Cancer research.

[77]  Fabian Kiessling,et al.  Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis , 2005, The Journal of experimental medicine.

[78]  S. Hayward,et al.  Loss of TGF-β type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-α-, MSP- and HGF-mediated signaling networks , 2005, Oncogene.

[79]  G. Collins.  The next generation. , 2006, Scientific American.

[80]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[81]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.

[82]  W. Muller,et al.  Addressing the Role of Cell Adhesion in Tumor Cell Dormancy , 2006, Cell cycle.

[83]  Mark W. Kieran,et al.  Identification of fibroblast heterogeneity in the tumor microenvironment , 2006, Cancer biology & therapy.

[84]  Richard A Flavell,et al.  Transforming growth factor-beta regulation of immune responses. , 2006, Annual review of immunology.

[85]  I. Konishi,et al.  Nuclear expression of S100A4 is associated with aggressive behavior of epithelial ovarian carcinoma: An important autocrine/paracrine factor in tumor progression , 2006, Cancer science.

[86]  E. Sahai,et al.  Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells , 2007, Nature Cell Biology.

[87]  Ross Tubo,et al.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.

[88]  Richard A Flavell,et al.  ‘Yin–Yang’ functions of transforming growth factor‐β and T regulatory cells in immune regulation , 2007, Immunological reviews.

[89]  R. J. Kelleher,et al.  Characterization of Human Lung Tumor-Associated Fibroblasts and Their Ability to Modulate the Activation of Tumor-Associated T Cells1 , 2007, The Journal of Immunology.

[90]  D. Hanahan,et al.  Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological Targeting , 2008, PLoS medicine.

[91]  I. Pinchuk,et al.  PD-1 ligand expression by human colonic myofibroblasts/fibroblasts regulates CD4+ T-cell activity. , 2008, Gastroenterology.

[92]  A. Bader,et al.  Multilineage differentiation potential of human dermal skin‐derived fibroblasts , 2008, Experimental dermatology.

[93]  F. Pépin,et al.  Stromal gene expression predicts clinical outcome in breast cancer , 2008, Nature Medicine.

[94]  Mina J Bissell,et al.  Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts. , 2008, Cancer research.

[95]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[96]  A. Ostman,et al.  Cancer-associated fibroblasts and tumor growth--bystanders turning into key players. , 2009, Current opinion in genetics & development.

[97]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[98]  Robert A. Gatenby,et al.  Environment-mediated drug resistance: a major contributor to minimal residual disease , 2009, Nature Reviews Cancer.

[99]  P. Fortina,et al.  The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma , 2009, Cell cycle.

[100]  David Allard,et al.  Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.

[101]  V. Rotter,et al.  Modulated expression of WFDC1 during carcinogenesis and cellular senescence , 2008, Carcinogenesis.

[102]  G. Watanabe,et al.  Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors , 2009, Clinical Cancer Research.

[103]  David Cameron,et al.  A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer , 2009, Nature Medicine.

[104]  N. Ohno,et al.  Rapid decrease of anti-β-glucan antibody as an indicator for early diagnosis of carinii pneumonitis and deep mycotic infections following immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis , 2009, Clinical Rheumatology.

[105]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[106]  S. Bao,et al.  The multifaceted role of periostin in tumorigenesis , 2009, Cellular and Molecular Life Sciences.

[107]  R. Xiang,et al.  Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model , 2009, PloS one.

[108]  Peter Olson,et al.  Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. , 2010, Cancer cell.

[109]  Louis Vermeulen,et al.  Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.

[110]  Kristian Pietras,et al.  Hallmarks of cancer: interactions with the tumor stroma. , 2010, Experimental cell research.

[111]  R. Kalluri,et al.  Methylation determines fibroblast activation and fibrogenesis in the kidney , 2010, Nature Medicine.

[112]  R. J. Kelleher,et al.  T Cells and Stromal Fibroblasts in Human Tumor Microenvironments Represent Potential Therapeutic Targets , 2010, Cancer Microenvironment.

[113]  C. Datz,et al.  Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver , 2010, Proceedings of the National Academy of Sciences.

[114]  Kornelia Polyak,et al.  The role of the microenvironment in mammary gland development and cancer. , 2010, Cold Spring Harbor perspectives in biology.

[115]  James O. Jones,et al.  Suppression of Antitumor Immunity by Stromal Cells Expressing , 2022 .

[116]  Bo Mu,et al.  Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model , 2010, Cancer science.

[117]  Michael J. Cronce,et al.  Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition , 2011, Proceedings of the National Academy of Sciences.

[118]  Jinghang Zhang,et al.  CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.

[119]  Anne E Carpenter,et al.  Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. , 2011, The Journal of clinical investigation.

[120]  D. Lewis,et al.  Reversing the aging stromal phenotype prevents carcinoma initiation , 2011, Aging.

[121]  C. Tatu,et al.  Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences , 2010, Journal of cellular and molecular medicine.

[122]  Y. Taniyama,et al.  Role of periostin in cancer progression and metastasis: inhibition of breast cancer progression and metastasis by anti-periostin antibody in a murine model. , 2011, International journal of molecular medicine.

[123]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[124]  Ricardo Garcia,et al.  Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis , 2011, Cell.

[125]  Raghu Kalluri,et al.  VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization , 2011, Proceedings of the National Academy of Sciences.

[126]  C. Betsholtz,et al.  Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. , 2011, Developmental cell.

[127]  D. Banerjee,et al.  Chemokines at the crossroads of tumor‐fibroblast interactions that promote malignancy , 2011, Journal of leukocyte biology.

[128]  Hiroyuki Tomita,et al.  Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. , 2011, Cancer cell.

[129]  M. Herlyn,et al.  Fibroblasts contribute to melanoma tumor growth and drug resistance. , 2011, Molecular pharmaceutics.

[130]  R. Kalluri,et al.  The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis. , 2011, Genes & cancer.

[131]  S. Conway,et al.  The Dynamic Role of Cardiac Fibroblasts in Development and Disease , 2012, Journal of Cardiovascular Translational Research.

[132]  Mina J Bissell,et al.  The tumor microenvironment is a dominant force in multidrug resistance. , 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[133]  Jane Fridlyand,et al.  Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors , 2012, Nature.

[134]  Hong Peng,et al.  Interactions between cancer stem cells and their niche govern metastatic colonization , 2011, Nature.

[135]  E. Giannoni,et al.  Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. , 2012, Cancer research.

[136]  Gerald C. Chu,et al.  Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.

[137]  Carlos Cuevas,et al.  Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.

[138]  J. Kleinman,et al.  Use of Postmortem Human Dura Mater and Scalp for Deriving Human Fibroblast Cultures , 2012, PloS one.

[139]  H. Sorg,et al.  Wound Repair and Regeneration , 2012, European Surgical Research.

[140]  Douglas Hanahan,et al.  Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types , 2022 .

[141]  Pierre Validire,et al.  Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. , 2012, The Journal of clinical investigation.

[142]  T. Golub,et al.  Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion , 2012, Nature.

[143]  Peiman Hematti,et al.  Mesenchymal stromal cells and fibroblasts: a case of mistaken identity? , 2012, Cytotherapy.

[144]  S. Andò,et al.  Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: Connecting TGF-β signaling with “Warburg-like” cancer metabolism and L-lactate production , 2012, Cell cycle.

[145]  C. Watson,et al.  Hypoxia-induced DNA hypermethylation in human pulmonary fibroblasts is associated with Thy-1 promoter methylation and the development of a pro-fibrotic phenotype , 2012, Respiratory Research.

[146]  R. Weinberg,et al.  Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. , 2012, Seminars in cancer biology.

[147]  P. Jung,et al.  Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. , 2012, Cancer cell.

[148]  G. Eberl,et al.  Lineage tracing and genetic ablation of ADAM12+ perivascular cells identify a major source of profibrotic cells during acute tissue injury , 2012, Nature Medicine.

[149]  Rakesh K Jain,et al.  Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease. , 2012, Cold Spring Harbor perspectives in medicine.

[150]  久德 真梨子.  Role of periostin in cancer progression and metastasis : inhibition of breast cancer progression and metastasis by anti-periostin antibody in a murine model , 2012 .

[151]  J. Epstein,et al.  Stromal epigenetic dysregulation is sufficient to initiate mouse prostate cancer via paracrine Wnt signaling , 2012, Proceedings of the National Academy of Sciences.

[152]  V. Speirs,et al.  Clinical and functional significance of loss of caveolin‐1 expression in breast cancer‐associated fibroblasts , 2012, The Journal of pathology.

[153]  B. Coulomb,et al.  The myofibroblast, multiple origins for major roles in normal and pathological tissue repair , 2012, Fibrogenesis & tissue repair.

[154]  M. Baron,et al.  Loss of PPARγ expression by fibroblasts enhances dermal wound closure , 2012, Fibrogenesis & tissue repair.

[155]  T. Kim,et al.  The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment. , 2012, Biochemical and biophysical research communications.

[156]  D. Newgreen,et al.  Contribution of Fibroblast and Mast Cell (Afferent) and Tumor (Efferent) IL-6 Effects within the Tumor Microenvironment , 2012, Cancer Microenvironment.

[157]  K. Pramanik,et al.  Immunomodulatory Properties of Mesenchymal Stem Cells: Cytokines and Factors , 2012, American journal of reproductive immunology.

[158]  J. Wrana,et al.  Free somatostatin receptor fraction predicts the antiproliferative effect of octreotide in a neuroendocrine tumor model: implications for dose optimization. , 2013, Cancer research.

[159]  K. Smalley,et al.  Fibroblast-mediated drug resistance in cancer. , 2013, Biochemical pharmacology.

[160]  Raghu Kalluri,et al.  Exosomes in tumor microenvironment influence cancer progression and metastasis , 2013, Journal of Molecular Medicine.

[161]  F. Sotgia,et al.  Oncogenes induce the cancer-associated fibroblast phenotype: Metabolic symbiosis and “fibroblast addiction” are new therapeutic targets for drug discovery , 2013, Cell cycle.

[162]  O. De Wever,et al.  Differential secretome analysis of cancer‐associated fibroblasts and bone marrow‐derived precursors to identify microenvironmental regulators of colon cancer progression , 2013, Proteomics.

[163]  Timothy Marsh,et al.  Fibroblasts as architects of cancer pathogenesis. , 2013, Biochimica et biophysica acta.

[164]  Fiona M. Watt,et al.  Distinct fibroblast lineages determine dermal architecture in skin development and repair , 2013, Nature.

[165]  Zhao-You Tang,et al.  Intratumoral α-SMA Enhances the Prognostic Potency of CD34 Associated with Maintenance of Microvessel Integrity in Hepatocellular Carcinoma and Pancreatic Cancer , 2013, PloS one.

[166]  D. Sidransky,et al.  Abstract 1287: Epigenetic deregulation of breast cancer is associated with DNA Repair Capacity. , 2013 .

[167]  Zhengyu He,et al.  Epigenetic regulation of Thy-1 gene expression by histone modification is involved in lipopolysaccharide-induced lung fibroblast proliferation , 2013, Journal of cellular and molecular medicine.

[168]  R. Kalluri,et al.  Origin and function of myofibroblasts in kidney fibrosis , 2013, Nature Medicine.

[169]  M. Egeblad,et al.  System-Wide Analysis Reveals a Complex Network of Tumor-Fibroblast Interactions Involved in Tumorigenicity , 2013, PLoS genetics.

[170]  T. Sjöblom,et al.  STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer. , 2013, Cancer research.

[171]  G. Kalna,et al.  Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma. , 2013, Cancer research.

[172]  E. Sonnhammer,et al.  Prognostic significance in breast cancer of a gene signature capturing stromal PDGF signaling. , 2013, The American journal of pathology.

[173]  Jeffrey T. Chang,et al.  Sheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transition. , 2013, Cancer letters.

[174]  Derek S. Chan,et al.  Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer , 2012, Gut.

[175]  O. Elemento,et al.  Metabolic Alterations in Lung Cancer–Associated Fibroblasts Correlated with Increased Glycolytic Metabolism of the Tumor , 2013, Molecular Cancer Research.

[176]  Darjus F. Tschaharganeh,et al.  Non-Cell-Autonomous Tumor Suppression by p53 , 2013, Cell.

[177]  Joseph M. Negri,et al.  The role of tumour–stromal interactions in modifying drug response: challenges and opportunities , 2013, Nature Reviews Drug Discovery.

[178]  D. Fearon,et al.  Tumoral Immune Suppression by Macrophages Expressing Fibroblast Activation Protein-α and Heme Oxygenase-1 , 2013, Cancer Immunology Research.

[179]  Sheng-Nan Lu,et al.  Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[180]  Robert P. Jenkins,et al.  Mechano-transduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer associated fibroblasts , 2013, Nature Cell Biology.

[181]  E. White,et al.  Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts , 2013, Cell Death and Disease.

[182]  D. Quail,et al.  Microenvironmental regulation of tumor progression and metastasis , 2014 .

[183]  Vincent H. Gattone,et al.  TGF-β1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis. , 2013, Journal of the American Society of Nephrology : JASN.

[184]  B. Parvin,et al.  Breast fibroblasts modulate early dissemination, tumorigenesis, and metastasis through alteration of extracellular matrix characteristics. , 2013, Neoplasia.

[185]  M. Zeisberg,et al.  The role of promoter hypermethylation in fibroblast activation and fibrogenesis , 2013, The Journal of pathology.

[186]  Dai Fukumura,et al.  Vascular normalization as an emerging strategy to enhance cancer immunotherapy. , 2013, Cancer research.

[187]  K. Sukhdeo,et al.  Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A , 2013, The Journal of experimental medicine.

[188]  S. Gordon,et al.  The M1 and M2 paradigm of macrophage activation: time for reassessment , 2014, F1000prime reports.

[189]  R. Kalluri,et al.  Cardiac biology: Cell plasticity helps hearts to repair , 2014, Nature.

[190]  Ping Li,et al.  Idiopathic pulmonary fibrosis will increase the risk of lung cancer. , 2014, Chinese medical journal.

[191]  A. Poggi,et al.  Mechanisms of tumor escape from immune system: role of mesenchymal stromal cells. , 2014, Immunology letters.

[192]  Christian M. Metallo,et al.  Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis. , 2014, Cancer cell.

[193]  Stephen A. Sastra,et al.  Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. , 2014, Cancer cell.

[194]  S. Mehrotra,et al.  Th17 Cells in Cancer: The Ultimate Identity Crisis , 2014, Front. Immunol..

[195]  S. Tartare-Deckert,et al.  LIF mediates proinvasive activation of stromal fibroblasts in cancer. , 2014, Cell reports.

[196]  Y. Okada,et al.  Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state , 2014, Nature Cell Biology.

[197]  M. Zeisberg,et al.  Contribution of genetics and epigenetics to progression of kidney fibrosis. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[198]  Eshel Ben-Jacob,et al.  Towards elucidating the connection between epithelial–mesenchymal transitions and stemness , 2014, Journal of The Royal Society Interface.

[199]  A. Desmoulière,et al.  Fibroblasts and myofibroblasts in wound healing , 2014, Clinical, cosmetic and investigational dermatology.

[200]  Å. Borg,et al.  Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties. , 2014, Cancer research.

[201]  T. Vondriska,et al.  Mesenchymal-endothelial-transition contributes to cardiac neovascularization , 2014, Nature.

[202]  Ker-Chau Li,et al.  Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling , 2014, Nature Communications.

[203]  R. Kalluri,et al.  Corrigendum: PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis , 2014, Nature Cell Biology.

[204]  Stefan Liebau,et al.  A Comparative View on Human Somatic Cell Sources for iPSC Generation , 2014, Stem cells international.

[205]  Peter Carmeliet,et al.  Metabolism of stromal and immune cells in health and disease , 2014, Nature.

[206]  John M. Asara,et al.  Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function , 2014, Nature.

[207]  T. Sjöblom,et al.  Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15. , 2014, Cancer research.

[208]  Wanli Deng,et al.  Epithelial-Mesenchymal Transition and Drug Resistance: Role, Molecular Mechanisms, and Therapeutic Strategies , 2014, Oncology Research and Treatment.

[209]  Janna Paulsson,et al.  Prognostic relevance of cancer-associated fibroblasts in human cancer. , 2014, Seminars in cancer biology.

[210]  Daniel Öhlund,et al.  Fibroblast heterogeneity in the cancer wound , 2014, The Journal of experimental medicine.

[211]  T. Kijima,et al.  Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis , 2014, Patient preference and adherence.

[212]  Marc L. Mendillo,et al.  The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy , 2014, Cell.

[213]  G. Wahl,et al.  Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy , 2014, Cell.

[214]  Amy A. Mrazek,et al.  Colorectal Cancer-Associated Fibroblasts are Genotypically Distinct. , 2014, Current cancer therapy reviews.

[215]  R. Sainson,et al.  Regulation of the anti-tumour immune response by cancer-associated fibroblasts. , 2014, Seminars in cancer biology.

[216]  M. Augsten.  Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor Microenvironment , 2014, Front. Oncol..

[217]  C. Tschöpe,et al.  Crosstalk between fibroblasts and inflammatory cells. , 2014, Cardiovascular research.

[218]  Janna Paulsson,et al.  PDGF receptors in tumor biology: prognostic and predictive potential. , 2014, Future oncology.

[219]  F. Sotgia,et al.  Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth. , 2014, Seminars in cancer biology.

[220]  M. Mareel,et al.  Carcinoma-associated fibroblasts provide operational flexibility in metastasis. , 2014, Seminars in cancer biology.

[221]  D. Brenner,et al.  Contribution of bone marrow-derived fibrocytes to liver fibrosis. , 2015, Hepatobiliary surgery and nutrition.

[222]  Mei Bigliardi-Qi,et al.  Fibroblast heterogeneity and its implications for engineering organotypic skin models in vitro. , 2015, European journal of cell biology.

[223]  P. Carmeliet,et al.  The Cancer Cell Oxygen Sensor PHD2 Promotes Metastasis via Activation of Cancer-Associated Fibroblasts. , 2015, Cell reports.

[224]  R. Atit,et al.  Sustained β‐catenin activity in dermal fibroblasts promotes fibrosis by up‐regulating expression of extracellular matrix protein‐coding genes , 2015, The Journal of pathology.

[225]  J. Mi,et al.  Metabolic reprogramming of cancer-associated fibroblasts by IDH3α downregulation. , 2015, Cell reports.

[226]  R. Schreiber,et al.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression , 2015, Cell.

[227]  F. Watt,et al.  Understanding fibroblast heterogeneity in the skin. , 2015, Trends in cell biology.

[228]  Umar Mahmood,et al.  Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival. , 2015, Cancer cell.

[229]  L. Mishra,et al.  EMT, CTCs and CSCs in tumor relapse and drug-resistance , 2015, Oncotarget.

[230]  Erik Sahai,et al.  Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling , 2015, Cancer cell.

[231]  J. Dittmer,et al.  The impact of tumor stroma on drug response in breast cancer. , 2015, Seminars in cancer biology.

[232]  Giuseppe Merlino,et al.  Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression. , 2015, Seminars in cancer biology.

[233]  S. Turley,et al.  Immunological hallmarks of stromal cells in the tumour microenvironment , 2015, Nature Reviews Immunology.

[234]  V. Sanz-Moreno,et al.  Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts , 2015, Nature Communications.

[235]  G. Charras,et al.  Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis , 2015, EMBO reports.

[236]  Victor D. Varner,et al.  Localized Smooth Muscle Differentiation Is Essential for Epithelial Bifurcation during Branching Morphogenesis of the Mammalian Lung. , 2015, Developmental cell.

[237]  F. Dazzi,et al.  Classification and biology of tumour associated stromal cells. , 2015, Immunology letters.

[238]  Ying Yu,et al.  Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment , 2015, Cell Research.

[239]  Lei Mu,et al.  Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer , 2015, PloS one.

[240]  Erik Sahai,et al.  Mesenchymal Cancer Cell-Stroma Crosstalk Promotes Niche Activation, Epithelial Reversion, and Metastatic Colonization , 2015, Cell reports.

[241]  Dong Eun Kim,et al.  Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation , 2015, Nature Cell Biology.

[242]  L. Mahadevan,et al.  Bending Gradients: How the Intestinal Stem Cell Gets Its Home , 2015, Cell.

[243]  J. Hanaoka,et al.  Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine , 2015, Cancer science.

[244]  Genichiro Ishii,et al.  Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment. , 2016, Advanced drug delivery reviews.

[245]  A. Bhatt,et al.  Role of interleukin-6 in cancer progression and therapeutic resistance , 2016, Tumor Biology.

[246]  C. Isacke,et al.  Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness , 2016, Nature Communications.

[247]  A. Viola,et al.  T Cells and Cancer: How Metabolism Shapes Immunity , 2016, Front. Immunol..

[248]  O. De Wever,et al.  Fibroblast activation protein‐α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations , 2016, Molecular oncology.

[249]  Vasilis Aidinis,et al.  Lung cancer in patients with idiopathic pulmonary fibrosis. , 2017, Pulmonary pharmacology & therapeutics.